Full history for every metric is available with a Kvantra account
Key financial summary
Financials in HUF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | HUF bn | 567 | 631 | 803 | 805 | 858 | 929 | 925 | 964 |
| Operating profit | HUF bn | 301 | 312 | ||||||
| Net profit | HUF bn | 105 | 140 | 169 | 159 | 239 | 232 | 229 | 265 |
| EPS reported | HUF | 1,271 | 1,256 | ||||||
| Operating cashflow per share | HUF | 1,599 | 1,653 | ||||||
| Capex per share | HUF | 232.9 | 222.7 | ||||||
| FCF per share | HUF | 1,366 | 1,430 | ||||||
| Free cash flow | HUF bn | 250 | 261 | ||||||
| Net debt | HUF bn | -237 | -306 | ||||||
| Book value equity | HUF bn | 1,398 | 1,458 | ||||||
| Book value per share | HUF | 7,650 | 7,992 | ||||||
| Number of shares | m | 182.8 | 182.39 | ||||||
| DPS (TTM paid) | HUF | 655.5 | 655.5 |
Financial summary
Financials in HUF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 7.76 | 9.83 | ||||||
| P/B LTM | x | 1.29 | 1.53 | ||||||
| P/S LTM | x | 1.94 | 2.42 | ||||||
| P/FCF LTM | x | 7.22 | 8.57 | ||||||
| EV/EBITDA LTM | x | 4.50 | 5.53 | ||||||
| EV/Sales LTM | x | 1.75 | 2.09 | ||||||
| Earnings Yield LTM | % | 12.89% | 10.17% | ||||||
| FCF Yield | % | 13.85% | 11.66% | ||||||
| Quality | |||||||||
| ROE | % | 16.61% | 16.73% | ||||||
| ROIC | % | 16.18% | 16.00% | ||||||
| Operating margin | % | 32.38% | 33.69% | ||||||
| Gross margin | % | 68.99% | 67.55% | ||||||
| FCF/Sales | % | 26.88% | 28.19% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -2.75% | -3.89% | ||||||
| Sales Growth YoY | % | +8.33% | +5.35% | ||||||
| Net Income Growth YoY | % | -2.89% | -4.05% | ||||||
| FCF Growth | % | +2.31% | +8.00% | ||||||
| Operating Profit Growth | % | +17.43% | +19.32% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 5.16% | 5.31% | ||||||
| Dividend Growth | % | +51.50% | +51.50% | ||||||
| Payout Ratio | % | 40.06% | 40.58% | ||||||
| FCF/Debt | x | 7.08 | 12.38 | ||||||
| Net Debt/EBITDA | x | -0.49 | -0.69 | ||||||
| EBIT/Net interest | x | 28.58 | 5.81 | ||||||
| Net debt/market cap | % | -13.14% | -13.68% | ||||||
| Net debt/Equity | x | -0.17 | -0.21 | ||||||
| Gross debt/equity | x | 0.03 | 0.01 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free